Abstract |
Most soluble lysosomal proteins bind the mannose 6-phosphate receptor (M6P-R) to be sorted to the lysosomes. However, the lysosomes of I-cell disease (ICD) patients, a condition resulting from a mutation in the phosphotransferase that adds mannose 6-phosphate to hydrolases, have near normal levels of several lysosomal proteins, including the sphingolipid activator proteins (SAPs), GM2AP and prosaposin. We tested the hypothesis that SAPs are targeted to the lysosomal compartment via the sortilin receptor. To test this hypothesis, a dominant-negative construct of sortilin and a sortilin small interfering RNA ( siRNA) were introduced into COS-7 cells. Our results showed that both the truncated sortilin and the sortilin siRNA block the traffic of GM2AP and prosaposin to the lysosomal compartment. This observation was confirmed by a co-immunoprecipitation, which demonstrated that GM2AP and prosaposin are interactive partners of sortilin. Furthermore, a dominant-negative mutant GGA prevented the trafficking of prosaposin and GM2AP to lysosomes. In conclusion, our results show that the trafficking of SAPs is dependent on sortilin, demonstrating a novel lysosomal trafficking.
|
Authors | Stephane Lefrancois, Jibin Zeng, A Jacob Hassan, Maryssa Canuel, Carlos R Morales |
Journal | The EMBO journal
(EMBO J)
Vol. 22
Issue 24
Pg. 6430-7
(Dec 15 2003)
ISSN: 0261-4189 [Print] England |
PMID | 14657016
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adaptor Proteins, Vesicular Transport
- Glycoproteins
- Membrane Glycoproteins
- Nerve Tissue Proteins
- PSAP protein, human
- RNA, Small Interfering
- Receptor, IGF Type 2
- Recombinant Fusion Proteins
- Saposins
- Sphingolipid Activator Proteins
- sortilin
|
Topics |
- Adaptor Proteins, Vesicular Transport
- Animals
- COS Cells
- Chlorocebus aethiops
- Glycoproteins
(metabolism)
- Humans
- Kinetics
- Lysosomes
(metabolism)
- Membrane Glycoproteins
(metabolism)
- Mutagenesis
- Nerve Tissue Proteins
(metabolism)
- RNA, Small Interfering
(genetics)
- Receptor, IGF Type 2
(metabolism)
- Recombinant Fusion Proteins
(metabolism)
- Saposins
- Sequence Deletion
- Sphingolipid Activator Proteins
|